Brief: ImmuPharma PLC Provides CIDP P140 Clinical Program Update

ImmuPharma

12/04/2023 07:35

April 12 (Reuters) - ImmuPharma PLC  IMM.L :
    * IMMUPHARMA PLC  - CIDP P140 CLINICAL PROGRAM UPDATE
    * IMMUPHARMA PLC - RECEIVES CONFIRMATION OF PRE-IND MEETING
DATE
WITH FDA FOR A PHASE 2/3 ADAPTIVE STUDY OF P140 IN CIDP

Source text for Eikon:  ID:nRSL8829Va 
Further company coverage:  IMM.L 

 ((Reuters.Briefs@thomsonreuters.com;;))